Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was extended in our case — was relaxing and invigorating, because that predictable routine of online meetings, calls, and deadlines has returned. But what can you do? The world, after all, keeps spinning (although, it is not hard to get the impression from ongoing events that some may think our globe is flat). To cope, yes, we are brewing cups of stimulation. Our choice today — cinnamon hazelnut. Feel free to join us. And now … here are your tidbits. Hope you have a smashing day, and do stay in touch. …
President Biden has yet to nominate a permanent head of the Food and Drug Administration at a time when the government is navigating a surge in Covid-19 cases from the Delta variant, The Hill notes. Some Democratic senators are pushing back on the prospects of acting Commissioner Janet Woodcock being named to the permanent role, but health care experts are warning the administration needs to fill the position immediately. White House press secretary Jen Psaki did not have an update on timing concerning the status of a permanent pick.
A letter supporting Janet Woodcock as permanent FDA commissioner that was signed by 95 oncologists is being held out as an example of the need for a fresh start at the top of the agency, STAT writes. Many of the physicians and researchers work for some of the most prestigious cancer centers and universities across the U.S., and nearly two-thirds of them accepted considerably more industry money than most doctors over the past several years.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
